<?xml version="1.0" encoding="UTF-8"?>
<p>All the new compounds were evaluated for their cytotoxicity against three cancer (MCF-7, A2780, and HT29) cell lines. Selection of these cell lines was based on previous findings which reported an overexpression of CDK-2 in breast, ovarian, and colon cancers
 <xref rid="CIT0008" ref-type="bibr">
  <sup>8â€“10</sup>
 </xref>.
</p>
